Considering that glucose intolerance and reduction in insulin sensitivity commonly occur together with basal dysglycemia and dyslipidemia, we assessed these two aspects in rats treated with bezafibrate to verify the impact of such treatment on these parameters. Here, INS is linked to Glucose intolerance.